CAPROCK Group Inc. purchased a new stake in Cognex Co. (NASDAQ:CGNX) in the 3rd quarter, HoldingsChannel reports. The fund purchased 3,967 shares of the scientific and technical instruments company’s stock, valued at approximately $221,000.

Several other large investors have also recently modified their holdings of the stock. Louisiana State Employees Retirement System lifted its position in Cognex by 2.4% in the 2nd quarter. Louisiana State Employees Retirement System now owns 46,700 shares of the scientific and technical instruments company’s stock worth $2,083,000 after buying an additional 1,100 shares in the last quarter. Envestnet Asset Management Inc. lifted its position in Cognex by 5.4% in the 2nd quarter. Envestnet Asset Management Inc. now owns 21,502 shares of the scientific and technical instruments company’s stock worth $960,000 after buying an additional 1,104 shares in the last quarter. Advisor Partners LLC lifted its position in Cognex by 26.6% in the 2nd quarter. Advisor Partners LLC now owns 5,418 shares of the scientific and technical instruments company’s stock worth $242,000 after buying an additional 1,140 shares in the last quarter. KBC Group NV lifted its position in Cognex by 2.8% in the 2nd quarter. KBC Group NV now owns 42,494 shares of the scientific and technical instruments company’s stock worth $1,896,000 after buying an additional 1,144 shares in the last quarter. Finally, Intrust Bank NA lifted its position in Cognex by 11.7% in the 2nd quarter. Intrust Bank NA now owns 13,085 shares of the scientific and technical instruments company’s stock worth $583,000 after buying an additional 1,366 shares in the last quarter. Institutional investors and hedge funds own 90.28% of the company’s stock.

In related news, Director Anthony Sun sold 10,000 shares of the firm’s stock in a transaction on Thursday, September 13th. The shares were sold at an average price of $56.04, for a total value of $560,400.00. Following the transaction, the director now directly owns 264,262 shares in the company, valued at approximately $14,809,242.48. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Jerry A. Schneider sold 5,000 shares of the firm’s stock in a transaction on Tuesday, September 11th. The shares were sold at an average price of $54.29, for a total transaction of $271,450.00. Following the completion of the transaction, the director now owns 7,000 shares in the company, valued at $380,030. The disclosure for this sale can be found here. Insiders sold a total of 27,500 shares of company stock worth $1,493,200 over the last quarter. 5.40% of the stock is currently owned by company insiders.

Shares of CGNX opened at $44.23 on Friday. Cognex Co. has a 12 month low of $39.90 and a 12 month high of $72.99. The firm has a market cap of $9.60 billion, a PE ratio of 31.06 and a beta of 1.64.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings results on Monday, July 30th. The scientific and technical instruments company reported $0.32 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.30 by $0.02. Cognex had a net margin of 20.57% and a return on equity of 22.95%. The company had revenue of $211.26 million for the quarter, compared to analyst estimates of $204.87 million. During the same quarter in the prior year, the business posted $0.63 EPS. Cognex’s quarterly revenue was up 18.6% on a year-over-year basis. Research analysts forecast that Cognex Co. will post 1.19 earnings per share for the current year.

Several research analysts have recently commented on CGNX shares. ValuEngine upgraded shares of Cognex from a “strong sell” rating to a “sell” rating in a research note on Tuesday, July 31st. Zacks Investment Research upgraded shares of Cognex from a “sell” rating to a “hold” rating in a research note on Tuesday, July 3rd. Morgan Stanley set a $52.00 price target on shares of Cognex and gave the stock a “hold” rating in a research note on Thursday, October 11th. Needham & Company LLC upgraded shares of Cognex from a “hold” rating to a “buy” rating and set a $52.00 price target on the stock in a research note on Tuesday. Finally, BidaskClub upgraded shares of Cognex from a “strong sell” rating to a “sell” rating in a research note on Saturday, July 7th. Four analysts have rated the stock with a sell rating, six have issued a hold rating and four have assigned a buy rating to the stock. Cognex currently has a consensus rating of “Hold” and a consensus price target of $54.28.

About Cognex

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate tasks primarily in manufacturing processes worldwide. The company offers machine vision products, which are used to automate the manufacturing and tracking of discrete items, such as mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Read More: Growth Stocks

Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX).

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.